Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALLO
MASS
Add up to 3 more stocks
ALLO
Allogene Therapeutics, Inc.
-2.67%
$1.46-0.04Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$503.93M
52W Range
$1.04 - $4.46
MASS
908 Devices Inc.
-3.67%
$12.33-0.47Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$505.87M
52W Range
$5.03 - $13.33
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.16 | 3.99 |
| P/S Ratio | 108.60 | 8.31 |
| P/FCF Ratio | N/A | 1049.51 |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 49.8% |
| Operating Margin | 0.0% | -46.0% |
| Net Margin | -3566.7% | -56.7% |
| ROE | -37.9% | -27.2% |
| ROA | -30.1% | -17.5% |
| ROIC | -34.8% | -18.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 10.72 | 2.67 |
| Quick Ratio | 10.72 | 2.38 |
| Debt/Equity | 0.16 | 0.03 |
| Interest Coverage | -192.50 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.